PremiumThe FlyMorning Movers: Stellantis skids following FY24 guidance cut Addex Therapeutics reports Q2 EPS CHF 0.08 vs. (CHF 0.04) last year Clinical Collaboration Ignites Addex Therapeutics (ADXN) Stock Rally PremiumThe FlyAddex Therapeutics Ltd – ADR trading resumes Addex Therapeutics Ltd – ADR trading halted, volatility trading pause Addex says ADX71149 didn’t achieve statistical significance for primary endpoint PremiumThe FlyAddex Therapeutics completes recruitment of patients in ADX71149 Addex Therapeutics regains compliance with Nasdaq Addex Therapeutics announces one for twenty reverse ADS split 
